Mark Lewallyn is a Partner based in New York where he focuses on strategic advice and M&A transaction execution for healthcare services & technology companies and private equity firms. He joined Centerview in 2016 as a founding member of its market-leading healthcare services and technology practice. Over the course of his career, he has advised on more than 50 transactions exceeding $250 billion in total deal value.

Representative transaction experience includes:

• Express Scripts on its $67 billion sale to Cigna

• Oak Street Health on its $11 billion sale to CVS Health

• Cigna on its $3.7 billion sale of its Medicare Businesses and CareAllies to HCSC

• Landmark Health on its $3.3 billion sale to Optum

• CareBridge on its sale to Elevance Health

• HealthSun on its $2.1 billion sale to Elevance Health

• Anthem on its $1.5 billion acquisition of America’s 1st Choice

• Humana on its $725mm acquisition of Enclara Pharmacy

• Molina Healthcare on its terminated acquisition of NextLevel Health

• Blackstone, Carlyle, and H&F on their $34 billion acquisition of Medline

• CPS on its sale to Optum

• Shields Health Solutions on its $2.5 billion sale to Walgreens

• Genoa Healthcare on its $2.5 billion sale to Optum

• BioPlus on its sale to Elevance Health

• CarepathRx Health System Solutions on its sale to Cigna

• Shields Health Solutions on its sale to Welsh Carson and Walgreens

• Pharmscript on its sale to Optum

• ExactCare on its $570mm acquisition of Tabula Rasa

• Cardinal Health on its $3.9 billion acquisition of GI Alliance

• OneOncology on its $2.1 billion sale to Cencora and TPG

• EyeCare Partners on its refinancing transactions

• InnovAge on its sale to Apax Partners

• OneOncology on its acquisition of United Urology

• Rural Medical Group on its acquisition of Steward Medical Group

• TA Associates on its acquisition of IMA Medical Group

• ICON on its $12 billion acquisition of PRA Health

• PPD on its $9.1 billion recap with Hellman & Friedman and Carlyle

• Syneos on its $7.1 billion sale to Elliott, Patient Square and Veritas

• INC Research on its $7 billion merger of equals with inVentiv Health

• inVentiv Health on its $3.7 billion sale to Advent

• Kohlberg on its acquisition of Worldwide Clinical Trials

• PharmaCord on its sale to Permira

• UBC, a subsidiary of Express Scripts, on its sale to Avista Capital

• MultiPlan on its $11 billion combination with Churchill Capital

• MedRisk on its sale to CVC Capital

• TransUnion RCM, a subsidiary of TransUnion, on its $1.7 billion sale to nThrive

• Kohlberg on its acquisition of Trinity Life Sciences

• Fresenius Medical in its participation in Humacyte’s $1.1 billion merger with Alpha Health

• Wellframe on its sale to Healthedge Software

• EQT on its acquisition of Certara

Before joining Centerview, Mr. Lewallyn worked in the Global Healthcare Group at Credit Suisse. Prior to pursuing a career in finance, he worked as an M&A and Capital Markets attorney in the New York office of Gibson, Dunn, & Crutcher.

He received his J.D. from the University of Virginia School of Law and his B.S. from Samford University where he was a four-year letterman on the Division 1 baseball team. He lives in Connecticut with his wife and two young children.